Xingfu Huang1, Yanjia Chen2, Junhui Xiao3, Hongxin Zhao4, Yizhen Chen1, Shenrong Liu1, Liwei He1, Zheng Huang1, Haobin Zhou1, Dingli Xu1, Jian Peng1. 1. Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 2. Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 3. Department of Cardiology, Huadu District People's Hospital, Southern Medical University, Guangzhou, Guangdong province, China. 4. Shanghai Roche Pharmaceuticals Ltd., Shanghai, China.
Abstract
BACKGROUND: We aimed to explore electrophysiological characteristics of premature atrial contractions (PACs) originating from pulmonary veins (PVs) and non-PVs and to evaluate the effectiveness and safety of catheter ablation for PACs. HYPOTHESIS: Symptomatic PACs originated from different positions and whether could be ablated. METHODS: Symptomatic, frequent, and drug-refractory PAC patients were enrolled in this study. All patients underwent electrophysiological study and catheter ablation. RESULTS: A total of 81 patients were enrolled: 45 patients with PACs originating from PVs (group A), 24 patients with PACs originating from non-PVs (group B), and 12 patients with PACs arising from both PVs and non-PVs (group C). Twenty (44.4%) patients in group A, 6 (50.0%) patients in group C, and 3 (12.5%) patients in group B presented paroxysmal atrial fibrillation (P < 0.05). PV isolation was performed in groups A and C. Focal ablation or superior vena cava isolation was performed in groups B and C, depending on patient condition. PACs were abolished in all patients except one patient in group B. During a median follow-up period of 21.3 ± 14.3 months, 40 (88.9%) patients in group A, 10 (83.3%) patients in group C, and 21 (87.5%) patients in group B were free of recurrence after initial ablation. CONCLUSIONS: Frequent PACs originating from PVs were associated with increased incidence of atrial fibrillation compared with PACs originating from non-PVs. Catheter ablation yields a satisfactory success rate and could be a good choice for eliminating symptomatic, frequent, and drug-refractory PACs.
BACKGROUND: We aimed to explore electrophysiological characteristics of premature atrial contractions (PACs) originating from pulmonary veins (PVs) and non-PVs and to evaluate the effectiveness and safety of catheter ablation for PACs. HYPOTHESIS: Symptomatic PACs originated from different positions and whether could be ablated. METHODS: Symptomatic, frequent, and drug-refractory PAC patients were enrolled in this study. All patients underwent electrophysiological study and catheter ablation. RESULTS: A total of 81 patients were enrolled: 45 patients with PACs originating from PVs (group A), 24 patients with PACs originating from non-PVs (group B), and 12 patients with PACs arising from both PVs and non-PVs (group C). Twenty (44.4%) patients in group A, 6 (50.0%) patients in group C, and 3 (12.5%) patients in group B presented paroxysmal atrial fibrillation (P < 0.05). PV isolation was performed in groups A and C. Focal ablation or superior vena cava isolation was performed in groups B and C, depending on patient condition. PACs were abolished in all patients except one patient in group B. During a median follow-up period of 21.3 ± 14.3 months, 40 (88.9%) patients in group A, 10 (83.3%) patients in group C, and 21 (87.5%) patients in group B were free of recurrence after initial ablation. CONCLUSIONS: Frequent PACs originating from PVs were associated with increased incidence of atrial fibrillation compared with PACs originating from non-PVs. Catheter ablation yields a satisfactory success rate and could be a good choice for eliminating symptomatic, frequent, and drug-refractory PACs.
Authors: Peter M Kistler; Kurt C Roberts-Thomson; Haris M Haqqani; Simon P Fynn; Suresh Singarayar; Jitendra K Vohra; Joseph B Morton; Paul B Sparks; Jonathan M Kalman Journal: J Am Coll Cardiol Date: 2006-08-17 Impact factor: 24.094
Authors: S A Chen; M H Hsieh; C T Tai; C F Tsai; V S Prakash; W C Yu; T L Hsu; Y A Ding; M S Chang Journal: Circulation Date: 1999-11-02 Impact factor: 29.690
Authors: Bo He; Yi Li; Weiping Huang; Wenxi Yu; Fang Zhao; Xiaoyan Wu; Shuyuan Yao; Sunny S Po; Zhibing Lu Journal: Front Cardiovasc Med Date: 2022-04-12